Heidi D. Klepin - Concepedia

Author

Heidi D. Klepin

Also Known As

H D Klepin, H Klepin, H. D. Klepin, H. Klepin, H.D. Klepin, Heidi D Klepin, Heidi D. Klepin, Heidi D. Klepin⁎, Heidi Klepin, Klepin, Heidi

341

Publications

11.6K

Citations

H-Index

110

Concepts

All Affiliations

Wake Forest University City of Hope Atrium Health Wake Forest Baptist Memorial Sloan Kettering Cancer Center University of Rochester Medical Center

About

Heidi D. Klepin is an author at Wake Forest University specializing in medicine, oncology, and geriatrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	40	3K
2	Health Sciences	11	13	2.1K
3	Public Health	8	8	313
4	Nursing	7	7	154
5	Cellular Therapies	1	1	17

Heidi D. Klepin

102

Publications

8.9K

Citations

H-Index

Page 1

	Year	Citations
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study Arti Hurria, Kayo Togawa, Supriya G. Mohile, Journal of Clinical Oncology	2011	1.8K
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology Supriya G. Mohile, William Dale, Mark R. Somerfield, Journal of Clinical Oncology Geriatric PsychiatryAgingCancer ManagementGeriatric MedicineAsco Guideline	2018	1.3K
Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer Arti Hurria, Supriya G. Mohile, Ajeet Gajra, Journal of Clinical Oncology	2016	589
Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia Heidi D. Klepin, Ann M. Geiger, Janet A. Tooze, Blood	2013	418
Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial Angela Alistar, Bonny Morris, Rodwige Desnoyer, The Lancet Oncology Pancreatic CancerModified FolfirinoxMedicinePharmacologyClinical Trials	2017	221
Frailty as determined by a comprehensive geriatric assessment‐derived deficit‐accumulation index in older patients with cancer who receive chemotherapy Harvey Jay Cohen, David Smith, Can‐Lan Sun, Cancer	2016	196
Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey David Waterhouse, R. Donald Harvey, Patricia A. Hurley, JCO Oncology Practice	2020	194
How Is Geriatric Assessment Used in Clinical Practice for Older Adults With Cancer? A Survey of Cancer Providers by the American Society of Clinical Oncology William Dale, Grant R. Williams, Amy R. MacKenzie, JCO Oncology Practice	2020	181
Polypharmacy and Potentially Inappropriate Medication Use in Older Adults with Cancer Undergoing Chemotherapy: Effect on Chemotherapy‐Related Toxicity and Hospitalization During Treatment Ronald J. Maggiore, William Dale, Cary P. Gross, Journal of the American Geriatrics Society	2014	142
The Feasibility of Inpatient Geriatric Assessment for Older Adults Receiving Induction Chemotherapy for Acute Myelogenous Leukemia Heidi D. Klepin, Ann M. Geiger, Janet A. Tooze, Journal of the American Geriatrics Society	2011	140

Page 1